Search

Your search keyword '"Hulkower S"' showing total 9 results
Start Over Author "Hulkower S" Journal journal of family practice
9 results on '"Hulkower S"'

1. Does XR injectable naltrexone prevent relapse as effectively as daily sublingual buprenorphine-naloxone?

Author

Roe M, Wilson CG, Fusco CW, Hulkower S, and Stigleman S

Subjects
Adult, Aged, Aged, 80 and over, Buprenorphine, Naloxone Drug Combination economics, Delayed-Action Preparations therapeutic use, Female, Humans, Male, Middle Aged, Narcotic Antagonists therapeutic use, Norway, United States, Administration, Sublingual, Buprenorphine, Naloxone Drug Combination administration & dosage, Buprenorphine, Naloxone Drug Combination therapeutic use, Delayed-Action Preparations administration & dosage, Injections, Intramuscular, Narcotic Antagonists administration & dosage, Opioid-Related Disorders drug therapy
Abstract

YES. MONTHLY EXTENDED-RELEASE INJECTABLE NALTREXONE (XR-NTX) TREATS OPIOID USE DISORDER AS EFFECTIVELY AS DAILY SUBLINGUAL BUPRENORPHINE-NALOXONE (BUP-NX) WITHOUT CAUSING ANY INCREASE IN SERIOUS ADVERSE EVENTS OR FATAL OVERDOSES. (STRENGTH OF RECOMMENDATION: A, 2 GOOD-QUALITY RCTS).

Published
2020

2. Which oral nonopioid agents are most effective for OA pain?

Author

Gilmer B, Hulkower S, Wilson CG, Macdonald B, Pozner J, and Stigleman S

Subjects
Humans, Osteoarthritis complications, Pain etiology, Analgesics, Non-Narcotic therapeutic use, Anti-Inflammatory Agents, Non-Steroidal therapeutic use, Osteoarthritis drug therapy, Pain drug therapy
Published
2019

3. Clinical Inquiries. How often does long-term PPI therapy cause clinically significant hypomagnesemia?

Author

Plaut T, Graeme K, Stigleman S, Hulkower S, and Woodall T

Subjects
Dose-Response Relationship, Drug, Humans, Time Factors, Anti-Ulcer Agents adverse effects, Anti-Ulcer Agents therapeutic use, Hypercholesterolemia etiology, Hypertension etiology, Magnesium blood, Proton Pump Inhibitors adverse effects, Proton Pump Inhibitors therapeutic use, Renal Tubular Transport, Inborn Errors etiology
Published
2018

4. Clinical Inquiries: What are the benefits and risks of daily low-dose aspirin for primary prevention of CV events?

Author

Mutter J, Grandy R, Hulkower S, and Stigleman S

Subjects
Adult, Aged, Aged, 80 and over, Female, Humans, Male, Middle Aged, Risk Assessment, Risk Factors, Aspirin adverse effects, Aspirin therapeutic use, Cardiovascular Diseases prevention & control, Gastrointestinal Hemorrhage chemically induced, Platelet Aggregation Inhibitors adverse effects, Platelet Aggregation Inhibitors therapeutic use, Primary Prevention methods
Abstract

One nonfatal myocardial infarction (MI) will be avoided for every 126 to 138 adults who take daily aspirin for 10 years (strength of recommendation [SOR]: A, systematic reviews and meta-analyses of multiple randomized controlled trials [RCTs]). Taking low-dose aspirin for primary prevention shows no clear mortality benefit. A benefit for primary prevention of stroke is less certain. Although no evidence establishes increased risk of hemorrhagic stroke from daily low-dose aspirin, one gastrointestinal hemorrhage will occur for every 72 to 357 adults who take aspirin for longer than 10 years (SOR: A, systematic reviews and meta-analyses of multiple RCTs and cohort studies).

Published
2018

5. Clinical inquiry: what is the best beta-blocker for systolic heart failure?

Author

Hulkower S, Aiken BA, and Stigleman S

Subjects
Adrenergic beta-Antagonists administration & dosage, Adrenergic beta-Antagonists adverse effects, Humans, Treatment Outcome, Adrenergic beta-Antagonists therapeutic use, Heart Failure, Systolic drug therapy
Abstract

Three beta-blockers--carvedilol, metoprolol succinate, and bisoprolol--reduce mortality equally (by about 30% over one year) in patients with Class III or IV systolic heart failure. Insufficient evidence exists comparing equipotent doses of these medications head-to-head to recommend any one over the others.

Published
2015

7. Clinical inquiries. What's the best treatment for sebaceous cysts?

Author

Moore RB, Fagan EB, Hulkower S, Skolnik DC, and O'Sullivan G

Subjects
Epidermal Cyst diagnosis, Evidence-Based Medicine, Family Practice, Female, Follow-Up Studies, Humans, Male, Risk Assessment, Skin Diseases diagnosis, Treatment Outcome, Biopsy, Needle methods, Epidermal Cyst surgery, Minimally Invasive Surgical Procedures methods, Skin Diseases surgery
Published
2007

9. Supraventricular tachycardia resistant to treatment in a pregnant woman.

Author

Treakle K, Kostic B, and Hulkower S

Subjects
Adult, Anti-Arrhythmia Agents therapeutic use, Drug Therapy, Combination, Electric Countershock, Female, Humans, Infant, Newborn, Pregnancy, Flecainide administration & dosage, Pregnancy Complications, Cardiovascular drug therapy, Propranolol administration & dosage, Tachycardia, Supraventricular drug therapy
Abstract

Supraventricular tachycardia is relatively common in pregnancy, and is related to the normal physiologic changes of the cardiovascular system in the gravid state. When the arrhythmia is secondary to an ectopic atrial focus of automaticity, it can be particularly difficult to convert to a normal sinus rhythm with medications or DC cardioversion. A case of supraventricular tachycardia complicating a normal pregnancy and resistant to treatment is presented, with particular attention devoted to flecainide and propranolol, agents ultimately effective in this patient.

Published
1992

Catalog

Books, media, physical & digital resources
See catalog results